Skip to main content
SpringerLink
Log in

Genetics and Potential Treatments of Obesity

  • Chapter
The Management of Eating Disorders and Obesity

Part of the book series: Nutrition and Health ((NH))

  • 1694 Accesses

Abstract

The incidence of obesity and other comorbidities in the US population has increased dramatically during the past two decades. According to the Center for Disease Control, the number of states in the United States that have obesity prevalence rates greater than 15% has increased from none in 1985 and 1990 to 25 states in 1995 and 49 states in 2000 (Fig. 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998; 280:1374–1377.

    Article  CAS  Google Scholar 

  2. Wilding JP. Neuropeptides and appetite control. Diabet Med 2002; 19:619–627.

    Article  CAS  Google Scholar 

  3. Kahn RC. The role of obesity in diabetes mellitus. Curr Opin Endocrinol Diabet 1996;3:1–2.

    Article  Google Scholar 

  4. Kaplan LM. Genetics of obesity and body weight regulation. Curr Opin Endocrinol Diabet 2000; 7: 218–224.

    Article  CAS  Google Scholar 

  5. Hillebrand JJ, de Wied D, Adan RA. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002; 23:2283–2306.

    Article  CAS  Google Scholar 

  6. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002; 16:623–637.

    Article  CAS  Google Scholar 

  7. Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Perusse L, Bouchard C. The human obesity gene map: the 2002 update. Obes Res 2003; 11:313–367.

    CAS  Google Scholar 

  8. Segal NL, Allison DB. Twins and virtual twins: bases of relative body weight revisited. Int J Obes Relat Metab Disord 2002; 26:437–441.

    Article  CAS  Google Scholar 

  9. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 1996; 20: 501–506.

    CAS  Google Scholar 

  10. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature 2000; 404: 644–651.

    CAS  Google Scholar 

  11. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27:325–351.

    Article  CAS  Google Scholar 

  12. Allison DB, Pietrobelli A, Faith MS, Fontaine KR, Gropp E, Fernández JR. Genetic Influences on Obesity 2003.

    Google Scholar 

  13. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967:379–388.

    Article  CAS  Google Scholar 

  14. Michaud JL. The developmental program of the hypothalamus and its disorders. Clin Genet 2001; 60: 255–263.

    Article  CAS  Google Scholar 

  15. Halaas JL, Gajiwala KS, Maffei, M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543–546.

    Article  CAS  Google Scholar 

  16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.

    Article  CAS  Google Scholar 

  17. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. Obes Res 1996;4:101.

    CAS  Google Scholar 

  18. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903–908.

    Article  CAS  Google Scholar 

  19. Chua SC, Jr., Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271:994–996.

    Article  CAS  Google Scholar 

  20. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398–401.

    Article  CAS  Google Scholar 

  21. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282:1568–1575.

    Article  CAS  Google Scholar 

  22. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86:3448.

    Article  CAS  Google Scholar 

  23. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385:165–168.

    Article  CAS  Google Scholar 

  24. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88:131–141.

    Article  CAS  Google Scholar 

  25. Chagnon YC, Chen WJ, Perusse L, et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med 1997; 3:663–673.

    CAS  Google Scholar 

  26. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106:271–279.

    CAS  Google Scholar 

  27. Dubern B, Clement K, Pelloux V, et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and a-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001; 139:204–209.

    Article  CAS  Google Scholar 

  28. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348:1085–1095.

    Article  CAS  Google Scholar 

  29. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348:1096–1103.

    Article  CAS  Google Scholar 

  30. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98:1101–1106.

    CAS  Google Scholar 

  31. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7:1189–1192.

    Article  CAS  Google Scholar 

  32. Marsh DJ, Hollopeter G, Huszar D, et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 1999; 21:119–122.

    Article  CAS  Google Scholar 

  33. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999; 5:1066–1070.

    Article  CAS  Google Scholar 

  34. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19:155–157.

    Article  CAS  Google Scholar 

  35. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15:273–276.

    Article  CAS  Google Scholar 

  36. Hager J, Dina C, Francke S, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998; 20:304–308.

    Article  CAS  Google Scholar 

  37. Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes 1999; 48:643–644.

    Article  CAS  Google Scholar 

  38. Hixson JE, Almasy L, Cole S, et al. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 1999; 84:3187–191.

    Article  CAS  Google Scholar 

  39. Challis BG, Pritchard LE, Creemers JW, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002; 11:1997–2004.

    Article  CAS  Google Scholar 

  40. Fernandez JR, Tarantino LM, Hofer SM, Vogler GP, McClearn GE. Epistatic quantitative trait loci for alcohol preference in mice. Behav Genet 2000; 30:431–437.

    Article  CAS  Google Scholar 

  41. Capeless CG, Whitney G. The genetic basis of preference for sweet substances among inbred strains of mice: preference ratio phenotypes and the alleles of the Sac and dpa loci. Chem Senses 1995; 20:291–298.

    Article  CAS  Google Scholar 

  42. Li X, Inoue M, Reed DR, et al. High-resolution genetic mapping of the saccharin preference locus (Sac) and the putative sweet taste receptor (T1R1) gene (Gpr70) to mouse distal chromosome 4. Mamm Genome 2001; 12: 13–16.

    Article  CAS  Google Scholar 

  43. Max M, Shanker YG, Huang L, et al. Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet 2001; 28:58–63.

    Article  CAS  Google Scholar 

  44. Lewcock JW, Reed DR. Sweet successes. Neuron 2001; 31:515–517.

    Article  CAS  Google Scholar 

  45. de Castro JM, Plunkett SS. How genes control real world intake: palatability—intake relationships. Nutr 2001; 17:266–268.

    Article  Google Scholar 

  46. Moran TH. Cholecystokinin and satiety: current perspectives. Nutr 2000; 16:858–865.

    Article  CAS  Google Scholar 

  47. Weinsier RL, Hunter GR, Heini AF, Goran MI, Sell SM. The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am J Med 1998; 105:145–150.

    Article  CAS  Google Scholar 

  48. Howard BV, Bogardus C, Ravussin E, et al. Studies of the etiology of obesity in Pima Indians. Am J Clin Nutr 1991; 53:1577S–85S.

    CAS  Google Scholar 

  49. Wade AJ, Marbut MM, Round JM. Muscle fibre type and aetiology of obesity. Lancet 1990; 335: 805–808.

    Article  CAS  Google Scholar 

  50. Bray MS. Genomics, genes, and environmental interaction: the role of exercise. J Appl Physiol 2000; 88:788–792.

    CAS  Google Scholar 

  51. Montgomery HE, Marshall R, Hemingway H, et al. Human gene for physical performance. Nature 1998; 393:221–222.

    Article  CAS  Google Scholar 

  52. Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 1997; 235:79–82.

    Article  CAS  Google Scholar 

  53. Boss O, Samec S, Kuhne F, et al. Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature. J Biol Chem 1998; 273:5–8.

    Article  CAS  Google Scholar 

  54. Rolfe DF, Newman JM, Buckingham JA, Clark MG, Brand MD. Contribution of mitochondrial proton leak to respiration rate in working skeletal muscle and liver and to SMR. Am J Physiol 1999; 276:C692–C699.

    CAS  Google Scholar 

  55. Dionne IJ, Garant MJ, Nolan AA, et al. Association between obesity and a polymorphism in the B(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord 2002; 26:633–639.

    Article  CAS  Google Scholar 

  56. Large V, Hellstrom L, Reynisdottir S, et al. Human B-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte B-2 adrenoceptor function. J Clin Invest 1997; 100: 3005–3013.

    CAS  Google Scholar 

  57. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the B 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348–351.

    Article  CAS  Google Scholar 

  58. Garcia-Rubi E, Starling RD, Tchernof A, et al. Trp64Arg variant of the B3-adrenoceptor and insulin resistance in obese postmenopausal women. J Clin Endocrinol Metab 1998; 83:4002–4005.

    Article  CAS  Google Scholar 

  59. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the B 3-adrenergic-receptor gene. N Engl J Med 1995; 333:343–347.

    Article  CAS  Google Scholar 

  60. Shuldiner AR, Silver K, Roth J, Walston J. Beta 3-adrenoceptor gene variant in obesity and insulin resistance. Lancet 1996; 348:1584–1585.

    Article  CAS  Google Scholar 

  61. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339:953–959.

    Article  CAS  Google Scholar 

  62. Gordon-Larsen P, Adair LS, Popkin BM. The relationship of ethnicity, socioeconomic factors, and overweight in US adolescents. Obes Res 2003;11:121–129.

    Article  Google Scholar 

  63. Allison DB, Edlen-Nezin L, Clay-Williams G. Obesity among African American women: prevalence, consequences, causes, and developing research. Womens Health 1997; 3:243–274.

    CAS  Google Scholar 

  64. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72:694–701.

    CAS  Google Scholar 

  65. Nicklas BJ, Berman DM, Davis DC, Dobrovolny CL, Dennis KE. Racial differences in metabolic predictors of obesity among postmenopausal women. Obes Res 1999; 7:463–468.

    CAS  Google Scholar 

  66. Hunter GR, Weinsier RL, Darnell BE, Zuckerman PA, Goran MI. Racial differences in energy expenditure and aerobic fitness in premenopausal women. Am J Clin Nutr 2000; 71:500–506.

    CAS  Google Scholar 

  67. Lovejoy JC, Champagne CM, Smith SR, de Jonge L, Xie H. Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study. Am J Clin Nutr 2001; 74:90–95.

    CAS  Google Scholar 

  68. Wright NM, Papadea N, Veldhuis JD, Bell NH. Growth hormone secretion and bone mineral density in prepubertal black and white boys. Calcif Tissue Int 2002; 70:146–152.

    Article  CAS  Google Scholar 

  69. Wagner DR, Heyward VH. Measures of body composition in blacks and whites: a comparative review. Am J Clin Nutr 2000; 71:1392–1402.

    CAS  Google Scholar 

  70. Williams RC, Long JC, Hanson RL, Sievers ML, Knowler WC. Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type 2 diabetes in Pima Indians. Am J Hum Genet 2000; 66:527–538.

    Article  CAS  Google Scholar 

  71. Fernandez JR, Shriver MD, Beasley TM, et al. Association of African Genetic Admixture with Resting Metabolic Rate and Obesity Among Women. Obes Res 2003; 11:904–911.

    Google Scholar 

  72. Schadt EE, Monks SA, Drake TA, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422:297–302.

    Article  CAS  Google Scholar 

  73. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002; 298: 2345–2349.

    Article  CAS  Google Scholar 

  74. Ettinger MP, Littlejohn TW, Schwartz SL, et al. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA 2003; 289:1826–1832.

    Article  CAS  Google Scholar 

  75. Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003; 63: 908–914.

    Article  CAS  Google Scholar 

  76. van Baak MA, Hul GB, Toubro S, et al. Acute effect of L-796568, a novel B 3-adrenergic receptor agonist, on energy expenditure in obese men. Clin Pharmacol Ther 2002; 71:272–279.

    Article  Google Scholar 

  77. Fernández JR, Allison DB. Rimonabant Sanofi-Synthelabo. Curr Opin Investig Drugs 2004; 5: 430–435.

    Google Scholar 

  78. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84:491–495.

    Article  CAS  Google Scholar 

  79. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83:1263–1271.

    Article  CAS  Google Scholar 

  80. Kahle EB, Butz KG, Chua SC, et al. The rat corpulent (cp) mutation maps to the same interval on (Pgm1-Glut1) rat chromosome 5 as the fatty (fa) mutation. Obes Res 1997; 5(2):142–145.

    CAS  Google Scholar 

  81. Naggert JK, Fricker LD, Varlamov O, et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995; 10:135–142.

    Article  CAS  Google Scholar 

  82. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 1995; 4:223–230.

    Article  CAS  Google Scholar 

  83. Kapeller R, Moriarty A, Strauss A, et al. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin. J Biol Chem 1999; 274: 24,980–24,986.

    Article  CAS  Google Scholar 

  84. Kleyn PW, Fan W, Kovats SG, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996; 85:281–290.

    Article  CAS  Google Scholar 

  85. Noben-Trauth K, Naggert JK, North MA, Nishina PM. A candidate gene for the mouse mutation tubby. Nature 1996; 380:534–538.

    Article  CAS  Google Scholar 

  86. Moralejo DH, Wei S, Wei K, et al. Identification of quantitative trait loci for non-insulin-dependent diabetes mellitus that interact with body weight in the Otsuka Long-Evans Tokushima Fatty rat. Proc Assoc Am Physicians 1998; 110(6):545–558.

    CAS  Google Scholar 

  87. Adan RA, Vink T. Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders. Eur Neuropsychopharmacol 2001; 11(6):483–490.

    Article  CAS  Google Scholar 

  88. Jackson IJ. The mahogany mouse mutation: further links between pigmentation, obesity and the immune system. Trends Genet 1999; 15(11):429–431.

    Article  CAS  Google Scholar 

  89. Carrascosa JM, Molero JC, Fermin Y, Martinez C, Andres A, Satrustegui J. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats. Diabetes Obes Metab 2001; 3(4): 240–248.

    Article  CAS  Google Scholar 

  90. Kovacs P, van den Brandt J, Kloting I, et al. Genetic dissection of the syndrome X in the rat. Biochem Biophys Res Commun 2000; 269(3):660–665.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Physiology and Metabolism, Department of Nutrition Sciences and Section in Statistical Genetics, University of Alabama at Birmingham, Birmingham, AL

    José R. Fernández PhD

  2. Division of Physiology and Metabolism, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL

    José R. Fernández PhD

  3. Department of Pharmacology and Toxicology, Indiana University School of Medicine and PRN Consulting, Indianapolis, IN

    David J. Goldstein MD, PhD

Authors
  1. José R. Fernández PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Goldstein MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology and Toxicology, Indiana University School of Medicine and PRN Consulting, Indianapolis, IN

    David J. Goldstein MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.,Totowa,NJ

About this chapter

Cite this chapter

Fernández, J.R., Goldstein, D.J. (2005). Genetics and Potential Treatments of Obesity. In: Goldstein, D.J. (eds) The Management of Eating Disorders and Obesity. Nutrition and Health. Humana Press. https://doi.org/10.1385/1-59259-865-X:293

Download citation

  • DOI: https://doi.org/10.1385/1-59259-865-X:293

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-341-1

  • Online ISBN: 978-1-59259-865-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation